Gastrointestinal Cancers and Personalized Medicine
Gastrointestinal cancers, such as esophageal and gastric cancers, pancreatic cancers, hepatobiliary cancers, colorectal cancers and gastrointestinal stromal tumors, are frequently diagnosed at an advanced stage and have a dismal prognosis. Even in patients with potentially curative cancer, nearly 50...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (136 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545485704498 |
---|---|
ctrlnum |
(CKB)5680000000037524 (oapen)https://directory.doabooks.org/handle/20.500.12854/80968 (EXLCZ)995680000000037524 |
collection |
bib_alma |
record_format |
marc |
spelling |
Mini, Enrico edt Gastrointestinal Cancers and Personalized Medicine Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (136 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Gastrointestinal cancers, such as esophageal and gastric cancers, pancreatic cancers, hepatobiliary cancers, colorectal cancers and gastrointestinal stromal tumors, are frequently diagnosed at an advanced stage and have a dismal prognosis. Even in patients with potentially curative cancer, nearly 50\% will develop recurrent disease despite aggressive treatments. A number of biomarkers currently guide treatment decisions for patients with gastrointestinal neoplasms. Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, furthering oncology along the path to “personalized cancer medicine”. Future research efforts will focus on the identification of new biomarkers, moving existing biomarkers into earlier lines of therapy and evaluating new combinations of existing biomarkers and therapies.The aim of this Special Issue is to provide an overview of exciting new research in the area of gastrointestinal tumors that may establish innovative personalized management and precision medicine modalities for individualized care. English Medicine bicssc Pharmacology bicssc neutrophil-to-lymphocyte ratio lymphocyte-to-monocyte ratio prognosis rectal cancer mesorectum sphincter preserving molecular oncology precision medicine colorectal cancer targeted therapy molecular profiling pancreatic cysts thermal liquid biopsy differential scanning calorimetry diagnosis generalized linear models gene signature mRNA expression VANGL1 FFPE neurotoxicity oxaliplatin chemotherapy-induced peripheral neuropathy biomarker genomics neuropathy FOLFOX FOLFIRINOX XELOX gastrointestinal cancer LAG-3 immune checkpoint colon cancer survival microsatellite instability immunotherapy 3-0365-3808-9 3-0365-3807-0 Nobili, Stefania edt Mini, Enrico oth Nobili, Stefania oth |
language |
English |
format |
eBook |
author2 |
Nobili, Stefania Mini, Enrico Nobili, Stefania |
author_facet |
Nobili, Stefania Mini, Enrico Nobili, Stefania |
author2_variant |
e m em s n sn |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Gastrointestinal Cancers and Personalized Medicine |
spellingShingle |
Gastrointestinal Cancers and Personalized Medicine |
title_full |
Gastrointestinal Cancers and Personalized Medicine |
title_fullStr |
Gastrointestinal Cancers and Personalized Medicine |
title_full_unstemmed |
Gastrointestinal Cancers and Personalized Medicine |
title_auth |
Gastrointestinal Cancers and Personalized Medicine |
title_new |
Gastrointestinal Cancers and Personalized Medicine |
title_sort |
gastrointestinal cancers and personalized medicine |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (136 p.) |
isbn |
3-0365-3808-9 3-0365-3807-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT minienrico gastrointestinalcancersandpersonalizedmedicine AT nobilistefania gastrointestinalcancersandpersonalizedmedicine |
status_str |
n |
ids_txt_mv |
(CKB)5680000000037524 (oapen)https://directory.doabooks.org/handle/20.500.12854/80968 (EXLCZ)995680000000037524 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Gastrointestinal Cancers and Personalized Medicine |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1796649061565071360 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03266nam-a2200757z--4500</leader><controlfield tag="001">993545485704498</controlfield><controlfield tag="005">20231214132950.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202205s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000037524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/80968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000037524</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mini, Enrico</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gastrointestinal Cancers and Personalized Medicine</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (136 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gastrointestinal cancers, such as esophageal and gastric cancers, pancreatic cancers, hepatobiliary cancers, colorectal cancers and gastrointestinal stromal tumors, are frequently diagnosed at an advanced stage and have a dismal prognosis. Even in patients with potentially curative cancer, nearly 50\% will develop recurrent disease despite aggressive treatments. A number of biomarkers currently guide treatment decisions for patients with gastrointestinal neoplasms. Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, furthering oncology along the path to “personalized cancer medicine”. Future research efforts will focus on the identification of new biomarkers, moving existing biomarkers into earlier lines of therapy and evaluating new combinations of existing biomarkers and therapies.The aim of this Special Issue is to provide an overview of exciting new research in the area of gastrointestinal tumors that may establish innovative personalized management and precision medicine modalities for individualized care.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacology</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutrophil-to-lymphocyte ratio</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lymphocyte-to-monocyte ratio</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mesorectum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sphincter preserving</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular profiling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pancreatic cysts</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thermal liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">differential scanning calorimetry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">generalized linear models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene signature</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mRNA expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VANGL1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FFPE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxaliplatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy-induced peripheral neuropathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuropathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FOLFOX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FOLFIRINOX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XELOX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gastrointestinal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LAG-3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoint</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colon cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microsatellite instability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3808-9</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3807-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nobili, Stefania</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mini, Enrico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nobili, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:38:24 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-05-14 21:41:54 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337928300004498&Force_direct=true</subfield><subfield code="Z">5337928300004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337928300004498</subfield></datafield></record></collection> |